Clinical Trial Update: Ganetespib Window of Opportunity Study in Head and Neck Cancers [Phase 1]

View source ↗

Summary

A Phase 1 window-of-opportunity study of ganetespib in head and neck squamous cell carcinomas has been terminated, involving hypopharyngeal, laryngeal, oral cav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Squamous Cell Carcinoma
• Laryngeal Squamous Cell Carcinoma
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• Ganetespib (ganetespib)

Snippet

Sponsor: Emory University | Conditions: Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma | Phase 1 | Status: TERMINATED